September 10, 2018
Orexo wins appeal against Actavis on Zubsolv patent in the US
Media
September 10, 2018
Vicore Pharma expands VP01 (C21) clinical program to enable functional read out
September 06, 2018
BONESUPPORT to be Featured at the Annual Meeting of the European Bone & Joint Infection Society (EBJIS)
September 05, 2018
Invitation BONESUPPORT Capital Markets Days
September 04, 2018
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
September 03, 2018
Nexstim Plc reports results of the supplementary Phase III E-FIT trial
August 31, 2018
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
August 30, 2018
Carl-Johan Dalsgaard Appointed New CEO of Vicore Pharma
August 28, 2018
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
August 24, 2018
Save the date: BONESUPPORT Capital Markets Days to be held in Stockholm and London